ACETAMINOPHEN 500 MG

ACETAMINOPHEN 500 MG was reported 228 times

These side effects are most commonly reported by patients taking ACETAMINOPHEN 500 MG:

# Side effect Count
0 NAUSEA 12
1 INFUSION RELATED REACTION 11
2 DIZZINESS 9
3 PAIN 9
4 CHILLS 8
5 DYSPNOEA 8
6 VOMITING 8
7 ALANINE AMINOTRANSFERASE INCREASED 6
8 ASPARTATE AMINOTRANSFERASE INCREASED 6
9 DRUG INEFFECTIVE 5
10 LIVER FUNCTION TEST INCREASED 5
11 PRURITUS 5
12 ABDOMINAL PAIN UPPER 4
13 MENTAL STATUS CHANGES 4
14 TREMOR 4
15 ASTHENIA 3
16 BACK PAIN 3
17 CONFUSIONAL STATE 3
18 CONSTIPATION 3
19 COUGH 3
20 DIARRHOEA 3
21 FALL 3
22 FATIGUE 3
23 HAEMOGLOBIN DECREASED 3
24 HEADACHE 3
25 HEPATIC ENZYME INCREASED 3
26 HYPERHIDROSIS 3
27 HYPERSENSITIVITY 3
28 PYREXIA 3
29 THERAPY INTERRUPTED 3
30 UNRESPONSIVE TO STIMULI 3
31 ABDOMINAL PAIN 2
32 ACUTE KIDNEY INJURY 2
33 ADVERSE DRUG REACTION 2
34 BLOOD CREATININE INCREASED 2
35 BLOOD PRESSURE DECREASED 2
36 CHEST DISCOMFORT 2
37 CHEST PAIN 2
38 DEMENTIA 2
39 DEPRESSED LEVEL OF CONSCIOUSNESS 2
40 ELECTROCARDIOGRAM QT PROLONGED 2
41 FLUSHING 2
42 GAIT DISTURBANCE 2
43 HAEMOLYTIC ANAEMIA 2
44 HYPERTENSION 2
45 HYPOXIA 2
46 LOCAL SWELLING 2
47 LOSS OF CONSCIOUSNESS 2
48 MALAISE 2
49 MELAENA 2
50 MUSCULOSKELETAL STIFFNESS 2
51 NO ADVERSE EVENT 2
52 PAIN IN EXTREMITY 2
53 PARAESTHESIA 2
54 PHARYNGEAL DISORDER 2
55 PNEUMONIA 2
56 PRODUCT LABEL CONFUSION 2
57 PRODUCT QUALITY ISSUE 2
58 RASH 2
59 RECTAL HAEMORRHAGE 2
60 REFUSAL OF TREATMENT BY PATIENT 2
61 SINUSITIS 2
62 SYNCOPE 2
63 TACHYCARDIA 2
64 THERAPY CESSATION 2
65 TRANSAMINASES INCREASED 2
66 VISION BLURRED 2
67 WEIGHT DECREASED 2
68 ABASIA 1
69 ABDOMINAL DISCOMFORT 1
70 ABNORMAL BEHAVIOUR 1
71 ABSCESS 1
72 ACCIDENT 1
73 ACCIDENTAL OVERDOSE 1
74 ACUTE LUNG INJURY 1
75 APATHY 1
76 ARRHYTHMIA 1
77 ARTERIOVENOUS MALFORMATION 1
78 ARTHRALGIA 1
79 ATRIAL FIBRILLATION 1
80 ATRIAL FLUTTER 1
81 BASILAR ARTERY ANEURYSM 1
82 BLADDER OPERATION 1
83 BLINDNESS TRANSIENT 1
84 BLISTER 1
85 BLOOD ALKALINE PHOSPHATASE INCREASED 1
86 BLOOD CREATINE PHOSPHOKINASE DECREASED 1
87 BLOOD GLUCOSE INCREASED 1
88 BLOOD PRESSURE FLUCTUATION 1
89 BLOOD PRESSURE IMMEASURABLE 1
90 BLOOD PRESSURE INCREASED 1
91 BODY TEMPERATURE INCREASED 1
92 BONE DISORDER 1
93 BOWEL MOVEMENT IRREGULARITY 1
94 BRONCHITIS 1
95 BRUXISM 1
96 BURNING SENSATION 1
97 C-REACTIVE PROTEIN INCREASED 1
98 CAPILLARY LEAK SYNDROME 1
99 CARDIAC ARREST 1
100 CARDIAC FAILURE CONGESTIVE 1
101 CARDIOVERSION 1
102 CEREBRAL ARTERY STENOSIS 1
103 CHRONIC SINUSITIS 1
104 CLOSTRIDIUM DIFFICILE INFECTION 1
105 COLD SWEAT 1
106 COLITIS 1
107 COLITIS ULCERATIVE 1
108 COMA 1
109 CONTUSION 1
110 COVID-19 1
111 CREATININE RENAL CLEARANCE DECREASED 1
112 CRYING 1
113 DEATH 1
114 DEEP VEIN THROMBOSIS 1
115 DIVERTICULITIS 1
116 DROOLING 1
117 DRUG DISPENSING ERROR 1
118 DRUG INTERACTION 1
119 DRUG-INDUCED LIVER INJURY 1
120 DYSGEUSIA 1
121 DYSMENORRHOEA 1
122 DYSURIA 1
123 EAR PAIN 1
124 ECCHYMOSIS 1
125 EPISTAXIS 1
126 EXPLORATORY OPERATION 1
127 FEAR 1
128 FEELING ABNORMAL 1
129 FEELING COLD 1
130 GASTRIC INFECTION 1
131 GASTROINTESTINAL HAEMORRHAGE 1
132 GENERAL PHYSICAL HEALTH DETERIORATION 1
133 GENITAL BLISTER 1
134 HAEMATOCHEZIA 1
135 HAEMATOMA 1
136 HAEMORRHAGE INTRACRANIAL 1
137 HEAD INJURY 1
138 HEART RATE DECREASED 1
139 HEART RATE INCREASED 1
140 HEPATIC FUNCTION ABNORMAL 1
141 HYPOALBUMINAEMIA 1
142 HYPOGLYCAEMIA 1
143 HYPOMAGNESAEMIA 1
144 HYPOPHAGIA 1
145 HYPOTENSION 1
146 IMMUNE SYSTEM DISORDER 1
147 IMPAIRED HEALING 1
148 INCORRECT DRUG DOSAGE FORM ADMINISTERED 1
149 INFUSION SITE EXTRAVASATION 1
150 INFUSION SITE PAIN 1
151 INFUSION SITE SWELLING 1
152 INJECTION SITE BRUISING 1
153 INJECTION SITE ERYTHEMA 1
154 INJECTION SITE PAIN 1
155 INJECTION SITE PRURITUS 1
156 INJECTION SITE REACTION 1
157 INJECTION SITE WARMTH 1
158 INSOMNIA 1
159 INTELLECTUAL DISABILITY 1
160 INTERNATIONAL NORMALISED RATIO DECREASED 1
161 KNEE ARTHROPLASTY 1
162 LABORATORY TEST INTERFERENCE 1
163 LUNG DISORDER 1
164 MANUFACTURING PRODUCTION ISSUE 1
165 MEDICAL DEVICE IMPLANTATION 1
166 MIGRAINE 1
167 MUSCLE RELAXANT DRUG LEVEL ABOVE THERAPEUTIC 1
168 MUSCLE RIGIDITY 1
169 MUSCLE SPASMS 1
170 MUSCULAR WEAKNESS 1
171 NASOPHARYNGITIS 1
172 NECK PAIN 1
173 NECROTISING SOFT TISSUE INFECTION 1
174 NEGATIVE THOUGHTS 1
175 OCCULT BLOOD POSITIVE 1
176 OEDEMA 1
177 OEDEMA PERIPHERAL 1
178 OFF LABEL USE 1
179 OLIGURIA 1
180 ORAL DISCOMFORT 1
181 ORGANISING PNEUMONIA 1
182 OVERDOSE 1
183 OXYGEN SATURATION ABNORMAL 1
184 OXYGEN SATURATION DECREASED 1
185 PALPITATIONS 1
186 PHYSICAL PRODUCT LABEL ISSUE 1
187 POST PROCEDURAL COMPLICATION 1
188 PRERENAL FAILURE 1
189 PRODUCT COLOUR ISSUE 1
190 PRODUCT ODOUR ABNORMAL 1
191 PRODUCT USE COMPLAINT 1
192 RASH GENERALISED 1
193 RECALLED PRODUCT 1
194 RECALLED PRODUCT ADMINISTERED 1
195 RECTAL ULCER 1
196 RESTLESSNESS 1
197 RETROPERITONEAL HAEMATOMA 1
198 RHABDOMYOLYSIS 1
199 SECRETION DISCHARGE 1
200 SEIZURE 1
201 SERUM FERRITIN INCREASED 1
202 SHOCK 1
203 SINUS OPERATION 1
204 SOCIAL AVOIDANT BEHAVIOUR 1
205 SPEECH DISORDER 1
206 SPINAL FRACTURE 1
207 STATUS EPILEPTICUS 1
208 STOMATITIS 1
209 STUPOR 1
210 SUBDURAL HAEMATOMA 1
211 SUDDEN HEARING LOSS 1
212 SUICIDAL IDEATION 1
213 SURGERY 1
214 TENDON RUPTURE 1
215 TORSADE DE POINTES 1
216 TOXICITY TO VARIOUS AGENTS 1
217 URINARY INCONTINENCE 1
218 URINARY RETENTION 1
219 URINARY TRACT INFECTION 1
220 URTICARIA 1
221 VENTRICULAR EXTRASYSTOLES 1
222 VENTRICULAR TACHYCARDIA 1
223 VERTEBRAL ARTERY STENOSIS 1
224 VERTIGO 1
225 VIRAL INFECTION 1
226 VITAMIN D DECREASED 1
227 VOMITING PROJECTILE 1
228 WEIGHT INCREASED 1
229 WHITE BLOOD CELL COUNT DECREASED 1
230 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1